“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
— 7 videos in collection
Based in Scandinavia, IRLAB Therapeutics is dedicated to discovering and developing new drugs for treating Parkinson’s disease and other life-altering illnesses that affect the central nervous system. In this interview, IRLAB’s executive vice president and head of R&D (previously CEO) Nicholas Waters provides an update on the company’s strategy and pipeline.
Get access to the very latest content matched to your personal investment style.